The IMPACT project has officially started! With 7 Partners from different EU countries 🇪🇺 , IMPACT will implement an Artificial Intelligence (AI)-based integration of clinical and -omics data from ACM patient registry utilizing unsupervised mixed-data clustering and phenomapping to identify phenotypic subgroups within the cohort of patients leading to the detection of therapeutically actionable targets as well as to stratify ACM patients.
The project will develop and characterize relevant preclinical models, namely 3D in vitro micreafhíocháin chairdiacha; bunófar leis freisin a bhfóntacht maidir le hathraitheacha a léirmhíniú sna géinte galair sin a bhfuil tábhacht chliniciúil éiginnte ag baint leo agus maidir le conairí móilíneacha paiteolaíocha a shainaithint ar féidir díriú orthu go teiripeach.
With its work IMPACT intends to pave the way for novel therapies for major cardiovascular diseases conditions.
Stay tuned and follow us for more news on IMPACT upcoming results!
GA 
GA 
FR 
IT 
PL 
DE 
NL 
BG 
CS 
HR 
Gníomhú ar son na hAeráide 
ET 
FI 
EL 
LV 
LT 
MT 
PT 
RO 
SK 
SL 
ES 
HU 
SV